DEA Begins Inspecting Newly Registered Cannabis Dispensaries

Federal drug agents have begun showing up in person at state-licensed medical marijuana dispensaries, the first time the federal government has physically inspected operators it long treated as criminals. The visits target businesses that registered with the Drug Enforcement Administration to capture the benefits of cannabis rescheduling, and they make clear that federal protection now comes with federal scrutiny.

The Mississippi Medical Marijuana Association said two of its member dispensaries, in Jackson and Meridian, were visited by federal officials last week and were told they were among the first operators in the country inspected under the new framework. Five to six DEA representatives spent hours at each site — about six hours at one Jackson location, according to the association — touring the facilities and asking detailed questions about how the businesses run day to day.

The association’s director described the encounters as collaborative and inquisitive rather than adversarial, with agents who appeared nearly as new to the process as the operators they were questioning. That posture matches how the rescheduling rule was written, but it lands on an industry that had never before opened its doors to a federal investigator.

Why registration invites the DEA in

The inspections flow directly from the final rule the Justice Department issued in April, which took effect April 28, 2026. The order moved marijuana sold under a state medical license, along with FDA-approved cannabis medicines, from Schedule I to Schedule III of the Controlled Substances Act. That shift ended the federal tax penalty that blocks cannabis businesses from deducting ordinary expenses — the single largest financial prize of the rescheduling move, and the reason operators are lining up to register.

The relief is not automatic. To claim Schedule III status, a dispensary has to register with the DEA, and registration converts a state licensee into a federal registrant bound by federal recordkeeping, security, and inventory rules, and open to DEA inspection. The agency opened its dispensary registration portal in late April and set a 60-day priority window, which closed in late June, for operators seeking expedited review.

The rule leans heavily on oversight that states already perform. It credits state programs with building “robust infrastructure” for preventing diversion, keeping records, and inspecting facilities, and it directs the DEA to accept state records and state security standards where it can. The Justice Department cast the approach as cooperative federalism meant to cause the least disruption to patients and existing state systems. What it left intact is the DEA’s own authority to walk in and verify that operators match their applications.

What the DEA is asking for

In Mississippi, that verification meant agents arriving without a formal checklist and requesting documents on the spot, the association said. The dispensaries are already licensed and inspected by the Mississippi State Department of Health, but the federal requests went well beyond routine state compliance.

Among the materials the association said the DEA sought:

• Ownership and license-transfer history, plus the names, contact information and Social Security numbers of every owner, along with any other businesses those owners hold an interest in
• Any communications with state regulators about fines or violations
• A complete product inventory and purchase history pulled from METRC, the state’s seed-to-sale tracking system
• Vendor lists and a written explanation of how the dispensary decides what to stock
• Employee records, training materials, and a full security plan, down to the hardware and software running the cameras

Some of that mirrors federal rules now binding on registrants. The rule requires every DEA registrant to take a fresh inventory of all stock every two years, and operators were told to keep filing those counts. The application goes further, asking whether a business handles recreational marijuana and whether anyone involved has ever handled a controlled substance without DEA authorization — an awkward question for nearly every operator, given that state-licensed cannabis was federally illegal until this spring.

At least one Jackson owner judged the trade-off worth it, the association relayed, treating the agents as another set of eyes rather than a threat and pointing to the tax deductions registration unlocks. The collaborative tone, though, depends on a framework that is still being built in real time.

What operators should watch

Mississippi is an early test, not the full picture. Only businesses licensed under a state medical program qualify, which is why Washington regulators have said rescheduling does not appear to reach their licensees at all. The DEA has also signaled it will extend registration beyond dispensaries to manufacturers, distributors and testing labs, which would pull far more of the supply chain into on-site federal review.

The larger question — whether all marijuana, including adult-use, eventually joins medical cannabis in Schedule III — remains unsettled. The DEA is scheduled to hold a hearing on broader rescheduling on June 29, 2026, with several states, anti-legalization groups and drug-testing interests positioned to oppose it. For now, the operators who moved fastest to claim the tax break are also the first to find out what continuous federal oversight feels like.